We used hrCRT to confirm the specific binding of the commercial anti-CRT Ab used in Western blot, although hrCRT displayed a slightly higher molecular mass compared with naturally occurring CRT in RA-FLS, probably because of posttranslation modifications in Escherichia coli. The gene discussed is CALR; the disease is rheumatoid arthritis.